Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer
Clinical trial NCT04549207 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04549207
- Sponsor
- Ottawa Hospital Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-09
- Primary completion
- 2025-04-17
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.